Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 49 (2015): Issue 2 (June 2015)
Open Access
Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
Ana Perpar
Ana Perpar
,
Erik Brecelj
Erik Brecelj
,
Nada Rotovnik Kozjek
Nada Rotovnik Kozjek
,
Franc Anderluh
Franc Anderluh
,
Irena Oblak
Irena Oblak
,
Marija Skoblar Vidmar
Marija Skoblar Vidmar
and
Vaneja Velenik
Vaneja Velenik
| Mar 25, 2015
Radiology and Oncology
Volume 49 (2015): Issue 2 (June 2015)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Mar 25, 2015
Page range:
181 - 184
Received:
Dec 10, 2013
Accepted:
Jan 23, 2014
DOI:
https://doi.org/10.2478/raon-2014-0024
Keywords
rectal cancer
,
capecitabine
,
acute mesenteric ischemia
,
multiorgan failure
,
short bowel syndrome
© by Vaneja Velenik
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.